Skip to main content

Rapid Diagnostics and Vaccination Strategy Preparedness

Fast diagnosis and containment of disease outbreaks are critical considerations in a risk preparedness strategy for an emergency animal disease outbreak. This project aims to deliver improved diagnostic capabilities (better tests and staff skilled in conducting these tests) and identify vaccines that have been shown to be effective against foot-and-mouth disease.

The Rapid Diagnostics and Vaccination Strategy Preparedness Project will:

  • improve Australia’s understanding and preparedness for the threat of emergency animal diseases such as foot-and-mouth disease (FMD)
  • Improve Australia’s ability to perform post-outbreak surveillance and return to trade
  • enhance CSIRO-Australian Animal Health Laboratory capability to diagnose emergency animal diseases
  • Provide recommendations on any necessary future changes to the composition of Australia’s FMD vaccine bank
  • Build an international reputation as a country with excellent capabilities in the area of FMD research

Project team:

Dr Wilna Vosloo
CSIRO
Project leader
Dr Nagendra Singanallur
CSIRO
Research Scientist
Wilna is a research scientist who obtained her PhD in 1998 at the University of Cape Town, South Africa. She has worked on FMD for nearly 30 years. In 2008 she moved to Australia to take on a job at the CSIRO-Australian Animal Health Laboratory and is currently a Principal Research Scientist responsible for the FMD research programme at AAHL. She has managed Phases 1 and 2 of the FMD Risk Management Project, funded by MLA through funding provided by all the affected industries and managed by AHA.

Wilna serves as one of seven international members on the World Organisation for Animal Health (OIE) FMD ad hoc Group on the Evaluation of FMD Status of Member Countries and is the CEO of the Global FMD Research Alliance.  She also serves on the Vaccine Expert Advisory Group and Vaccine Bank Contract Committee in Australia.

Nagendra is a research scientist and a trained veterinarian.  He obtained his PhD in 2009 and has worked on FMD for nearly 17 years.  In 2011 he moved to Australia to take on a job at the CSIRO-Australian Animal Health Laboratory and is currently a Research Scientist within the FMD research program at AAHL.  He was actively involved in Phases 1 and 2 of the FMD Risk Management Project, funded by MLA through funding provided by all the affected industries and managed by AHA.  His research interests are characterisation of FMD isolates, vaccine matching and diagnostic tests development and validation.